Fresh analysis reveals that patients who discontinue blockbuster GLP-1 drugs like semaglutide or tirzepatide can put back on reduced body mass at a significantly accelerated pace than those who halt traditional lifestyle plans.
Findings released in a prominent medical journal demonstrates that while overweight people frequently drop a large proportion of their body weight while on the medication, the weight comes back at an average rate of 0.8 kg per month once they quit.
"Individuals using these drugs should be cognizant of the risk of fast rebound weight gain when the medication concludes," stated lead investigator Dr. Susan Jebb.
This pace of recovery implies a reversion to pre-treatment mass within about one and a half years.
Comparing Approaches
The research, which reviewed dozens of trials involving over 9,000 of patients, compared the results of these new drugs with other pills.
Researchers emphasize that people who shed pounds through diet and exercise generally see a slower weight regain—perhaps 100 grams monthly—post-intervention.
Explaining the Quick Rebound
Nutrition scientists propose the way of the drugs explains the amplified rebound.
These medications copy a body's own chemical called glucagon-like peptide-1, which moderates appetite.
"Sustained high doses of the hormone concentrations far above than normal might result in the body to generate a reduced amount of its own natural GLP-1, and could reduce sensitivity to its actions," explained Dr. Adam Collins, a nutrition expert.
"Discontinuation of this GLP-1 'fix' leads to hunger is uncontrolled, making overeating far more likely."
A Lifelong Disease?
Health authorities recommend the jabs for individuals with weight-linked medical conditions, alongside recommended lifestyle changes.
Professionals say that, given the significant potential of relapse, the therapy is often long-term.
This view is echoed by pharmaceutical companies, who say that the findings "highlight the chronic character of obesity," akin to managing conditions like high blood pressure.
User Testimonies
Users who have stopped the jabs describe a sudden return of cravings.
"I experienced something that goes on and I was suddenly ravenous," recalled one woman.
The struggle is exacerbated if individuals have not adopted permanent lifestyle or habit modifications during therapy.
Significant Interest
Recent estimates suggest that a significant number of adults in the UK have used these injections in the last 12 months, with interest being substantial.
- Use is more common among females compared to men.
- The middle-aged demographic shows the greatest usage rates.
- Many obtain the medications through private healthcare rather than public health services.
In conclusion, researchers stress that while GLP-1 drugs are potent tools for weight loss, they are not a permanent fix and lasting health benefits hinges on integrated lifestyle management.
